• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例系列:细胞学涂片能否提示胸腺瘤的组织学类型并区分胸腺瘤与胸腺癌?

A Case Series: Can a Cytological Smear Indicate the Histological Type of Thymoma and Distinguish Thymoma From Thymic Carcinoma?

作者信息

Gardić Nikola, Tomić Sonja, Miljković Dejan, Lovrenski Aleksandra

机构信息

Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia.

Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia.

出版信息

Diagn Cytopathol. 2025 Sep;53(9):E165-E169. doi: 10.1002/dc.25493. Epub 2025 Jun 4.

DOI:10.1002/dc.25493
PMID:40464409
Abstract

INTRODUCTION

The cytological characteristics of thymoma are not extensively documented in the literature, primarily due to the tumor's rarity. To our knowledge, there are no standardized criteria for the cytological classification of thymomas.

CASE REPORTS

We report three cases of female patients with cytological smears of thymic epithelial neoplasms, correlating them with the corresponding surgical specimens. In all three smears, the cytological features of the cells were similar and consisted of epithelial and lymphocytic components. Epithelial cells were approximately twice the size of lymphocytes, although some were five times larger, displaying prominent nucleoli and marked nuclear atypia. In many areas of the smears, prominent crush artifacts with chromatin streaking were observed in thymoma cases. The thymic carcinoma case had an inconspicuous crush artifact. The number of lymphocytes varied on the smears. In the smears of thymoma, we had a high number of lymphocytes intermixed with epithelial cells, while in thymic carcinoma, we have just a few scattered lymphocytes. In one case of thymoma, a higher number of mast cells were observed.

CONCLUSION

Preoperative diagnosis of mediastinal masses is essential for the future clinical management of these patients. As such, cytological diagnosis sometimes plays an important role, although the distinct cytological features of thymic epithelial lesions can be challenging. Our cases suggest specific cytological features that may help differentiate thymoma from thymic carcinoma.

摘要

引言

胸腺瘤的细胞学特征在文献中记录并不广泛,主要是因为该肿瘤较为罕见。据我们所知,目前尚无胸腺瘤细胞学分类的标准化标准。

病例报告

我们报告了3例女性胸腺上皮性肿瘤的细胞学涂片病例,并将其与相应的手术标本进行了对比。在所有3例涂片中,细胞的细胞学特征相似,均由上皮成分和淋巴细胞成分组成。上皮细胞大小约为淋巴细胞的两倍,有些则大五倍,可见明显的核仁及显著的核异型性。在涂片的许多区域,胸腺瘤病例可见明显的挤压伪像及染色质条纹。胸腺癌病例的挤压伪像不明显。涂片上淋巴细胞数量各异。在胸腺瘤涂片中,淋巴细胞数量较多,与上皮细胞混合存在,而在胸腺癌涂片中,仅见少数散在淋巴细胞。在1例胸腺瘤病例中,观察到较多肥大细胞。

结论

纵隔肿块的术前诊断对这些患者未来的临床治疗至关重要。因此,细胞学诊断有时发挥重要作用,尽管胸腺上皮性病变独特的细胞学特征可能具有挑战性。我们的病例提示了一些有助于区分胸腺瘤和胸腺癌的特定细胞学特征。

相似文献

1
A Case Series: Can a Cytological Smear Indicate the Histological Type of Thymoma and Distinguish Thymoma From Thymic Carcinoma?病例系列:细胞学涂片能否提示胸腺瘤的组织学类型并区分胸腺瘤与胸腺癌?
Diagn Cytopathol. 2025 Sep;53(9):E165-E169. doi: 10.1002/dc.25493. Epub 2025 Jun 4.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Thymoma: current diagnosis and treatment.胸腺瘤:当前的诊断与治疗。
Chin Med J (Engl). 2013;126(11):2186-91.
4
Chemotherapy for thymic carcinoma and advanced thymoma in adults.成人胸腺上皮癌和晚期胸腺瘤的化疗
Cochrane Database Syst Rev. 2013 Aug 23;2013(8):CD008588. doi: 10.1002/14651858.CD008588.pub2.
5
Case Report: Robust and durable response to the combination of tislelizumab and chemotherapy in advanced thymic epithelial tumors: a case series.病例报告:替雷利珠单抗联合化疗对晚期胸腺上皮肿瘤的强效持久反应:病例系列
Front Immunol. 2025 May 27;16:1516297. doi: 10.3389/fimmu.2025.1516297. eCollection 2025.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Lenvatinib plus pembrolizumab in pretreated metastatic B3 thymoma and thymic carcinoma (PECATI): a single-arm, phase 2 trial.乐伐替尼联合帕博利珠单抗治疗经治转移性B3胸腺瘤和胸腺癌(PECATI):一项单臂2期试验。
Lancet Oncol. 2025 Sep;26(9):1215-1226. doi: 10.1016/S1470-2045(25)00300-6.
8
Thymic carcinoma. Report of five cases and review of the literature.胸腺癌。5例报告及文献复习
J Cancer Res Clin Oncol. 1990;116(1):69-82. doi: 10.1007/BF01612643.
9
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
10
Sexual Harassment and Prevention Training性骚扰与预防培训